Gevo (GEVO) Stock Price, News & Analysis

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Gevo in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GEVO shares.
View GEVO analyst ratings or view top-rated stocks.

4 brokers have issued 12-month price targets for Gevo's shares. Their GEVO share price targets range from $0.85 to $14.00. On average, they expect the company's stock price to reach $4.76 in the next year. This suggests a possible upside of 581.8% from the stock's current price.
View analysts price targets for GEVO or view top-rated stocks among Wall Street analysts.

Gevo's stock was trading at $1.16 at the start of the year. Since then, GEVO shares have decreased by 39.8% and is now trading at $0.6985.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 8th 2024.
View our GEVO earnings forecast.

Gevo, Inc. (NASDAQ:GEVO) posted its quarterly earnings data on Thursday, March, 7th. The energy company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.03. The energy company earned $4.37 million during the quarter, compared to the consensus estimate of $4.26 million. Gevo had a negative trailing twelve-month return on equity of 11.97% and a negative net margin of 393.88%. During the same period in the prior year, the firm earned ($0.11) EPS.

ETFs with the largest weight of Gevo (NASDAQ:GEVO) stock in their portfolio include Xtrackers US Green Infrastructure Select Equity ETF (UPGR).ALPS Clean Energy ETF (ACES).

Shares of Gevo reverse split on the morning of Monday, June 4th 2018. The 1-20 reverse split was announced on Friday, June 1st 2018. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 1st 2018. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

7 employees have rated Gevo Chief Executive Officer Patrick Gruber on Glassdoor.com. Patrick Gruber has an approval rating of 15% among the company's employees. This puts Patrick Gruber in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Gevo investors own include Bionano Genomics (BNGO), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), Aeterna Zentaris (AEZS), Zosano Pharma (ZSAN), ADMA Biologics (ADMA), Matinas BioPharma (MTNB), Denison Mines (DNN), Novan (NOVN) and CBL & Associates Properties (CBL).

Gevo's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Thomist Capital Management LP (0.99%), BNP Paribas Financial Markets (0.06%), Mirae Asset Global Investments Co. Ltd. (0.05%), SG Americas Securities LLC (0.04%) and FinTrust Capital Advisors LLC (0.02%). Insiders that own company stock include Alisher K Nurmat, Andrew Marsh, Andrew Shafer, Christopher Michael Ryan, Gary W Mize, Geoffrey Thomas Jr Williams, Kimberly T Bowron, L Lynn Smull, Patrick R Gruber, Paul D Bloom and Timothy J Cesarek.
View institutional ownership trends.

Shares of GEVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.